<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01922440</url>
  </required_header>
  <id_info>
    <org_study_id>PAR-R13-001</org_study_id>
    <nct_id>NCT01922440</nct_id>
  </id_info>
  <brief_title>A Registry for Patients With Chronic Hypoparathyroidism</brief_title>
  <acronym>PARADIGHM</acronym>
  <official_title>PARADIGHM (Physicians Advancing Disease Knowledge in Hypoparathyroidism): A Registry for Patients With Chronic Hypoparathyroidism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shire</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shire</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, observational disease and drug registry designed to evaluate the
      safety and effectiveness profile of rhPTH(1-84) under conditions of routine clinical practice
      and to observe the clinical course of chronic hypoparathyrodism. No treatment is provided as
      a result of participating in this registry and all decisions on the participant's treatment
      are determined by his or her physician.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2013</start_date>
  <completion_date type="Anticipated">June 30, 2035</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2035</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Hypoparathyroidism Laboratory Test</measure>
    <time_frame>Baseline up to 10 years (follow-up)</time_frame>
    <description>Hypoparathyroidism laboratory tests will be evaluated as change over time for 24-hour urine calcium, serum calcium, serum magnesium, serum phosphate and 25-OH vitamin D.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Laboratory Test Results</measure>
    <time_frame>Baseline up to 10 years (follow-up)</time_frame>
    <description>Results of laboratory tests collected per standard of care.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Renal Function</measure>
    <time_frame>Baseline up to 10 years (follow-up)</time_frame>
    <description>Renal function will be evaluated as change over time for serum creatinine, estimated glomerular filtration rate (eGFR; calculated), 24-hour urine calcium and 24 hour urine protein.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of the Renal Events</measure>
    <time_frame>Baseline up to 10 years (follow-up)</time_frame>
    <description>Incidence rate of the renal events will be recorded for nephrolithiasis, nephrocalcinosis, hospitalization/emergency room visits for renal events.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of the Soft Tissue Calcifications (site)</measure>
    <time_frame>Baseline up to 10 years (follow-up)</time_frame>
    <description>Incidence rate of the soft tissue calcifications (site) will be recorded.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of the Cataract</measure>
    <time_frame>Baseline up to 10 years (follow-up)</time_frame>
    <description>Incidence rate of the cataract will be recorded by questionnaire (present/not present).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of the Bone Fractures (site)</measure>
    <time_frame>Baseline up to 10 years (follow-up)</time_frame>
    <description>Incidence rate of the bone fractures (site) will be recorded.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence Rate of the Cardiovascular Events</measure>
    <time_frame>Baseline up to 10 years (follow-up)</time_frame>
    <description>Incidence rate of the cardiovascular events will be calculated for this clinical outcome. Cardiovascular events include myocardial infarction, stroke, arrhythmia.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)</measure>
    <time_frame>Baseline up to 10 years (follow-up)</time_frame>
    <description>An adverse event (AE) is any noxious, pathologic, or unintended change in anatomical, physiologic, or metabolic function as indicated by physical signs, symptoms, or laboratory changes occurring in the registry, whether or not considered product-related. This includes an exacerbation of a pre - existing condition. An AE that meets one or m ore of the following criteria/outcomes is classified as SAE whether considered to be related to the pharmaceutical product or not: death, life-threatening, requires in patient hospitalization or prolongation of existing hospitalizations, a persistent or significant disability or incapacity, a congenital anomaly or birth defect and important medical events.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health-related Quality of Life (HRQoL)</measure>
    <time_frame>Baseline up to 10 years (follow-up)</time_frame>
    <description>Health-Related Quality of Life (HRQoL), as measured by the short-form-10 (SF-10) for pediatrics, short-form-36 (SF-36) for adults will be examined longitudinally using methods for continuous data.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease-specific Patient-reported Outcome Measures</measure>
    <time_frame>Baseline up to 10 years (follow-up)</time_frame>
    <description>Chronic hypoparathyroidism patient-reported outcome will be recorded as measured by the hypoparathyroidism multi-symptom diary (HPT-SD).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Hospitalization/Emergency Room (ER) Visits</measure>
    <time_frame>Baseline up to 10 years (follow-up)</time_frame>
    <description>The rate of hospitalizations and ER visits during follow-up will be summarized.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">900</enrollment>
  <condition>Chronic Hypoparathyroidism</condition>
  <arm_group>
    <arm_group_label>Chronic Hypoparathyroidism</arm_group_label>
    <description>A rare disease with a duration of longer than 6 months characterized by insufficient parathyroid hormone (PTH) secretion, which can result in hypocalcemia, hyperphosphatemia, and associated clinical findings.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Combination product (Natpara) and drug or supplements [Disease and drug registry]</intervention_name>
    <description>Interventions evaluated are combination product (Natpara) and either drug or supplements (Calcium and vitamin D)</description>
    <arm_group_label>Chronic Hypoparathyroidism</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This registry is designed to enroll globally at least 900 participants with chronic
        hypoparathyroidism, including a minimum of 300 participants who are receiving treatment
        with recombinant human parathyroid hormone, rhPTH (1-84) and a minimum of 600 participants
        who are receiving standard of care.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. Participants diagnosed with chronic hypoparathyroidism, ie, hypoparathyroidism with a
        duration of longer than 6 months, including:

          1. Adult participants (greater than or equal to [&gt;=] 18 years of age) who are receiving
             for chronic hypoparathyroidism any of the following options: standard therapy,
             standard therapy plus rhPTH(1-84), or rhPTH(1-84) therapy alone.

          2. Pediatric participants (less than [&lt;] 18 years of age) who are receiving for chronic
             hypoparathyroidism any of the following options: standard therapy, standard therapy
             plus rhPTH(1-84), or rhPTH(1-84) therapy alone.

        Exclusion Criteria:

          1. Participants or legally acceptable representatives unable to provide informed consent.

          2. Participants using rhPTH(1-34) or used rhPTH(1-34) for more than 2 years and in the
             last 3 months.

          3. Participants currently enrolled in an interventional clinical study (whether or not
             the study is related to hypoparathyroidism). Note that this does not include
             participants enrolled in other observational registries.

          4. History of hypoparathyroidism resulting from a known activating mutation in the CaSR
             gene.

          5. History of hypoparathyroidism resulting from impaired responsiveness to PTH
             (pseudohypoparathyroidism).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shire Study Physician</last_name>
    <role>Study Director</role>
    <affiliation>Shire</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shire Contact</last_name>
    <email>clinicaltransparency@shire.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kentress Davison</last_name>
      <phone>205-975-9308</phone>
      <email>kdavison@uab.edu</email>
    </contact>
    <investigator>
      <last_name>Amy Warriner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Arizona Medical Center</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85714</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Ambrose</last_name>
      <phone>520-626-3709</phone>
      <email>maeambrose@medadmin.arizona.edu</email>
    </contact>
    <investigator>
      <last_name>Craig Stump, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebeca Martinez</last_name>
      <phone>323-361-6478</phone>
      <email>rebmartinez@chla.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Pisit Pitukcheewanont, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cynthia Gudino</last_name>
      <phone>310-423-8321</phone>
      <email>cynthia.gudino@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Wendy Sacks, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emma Hulseberg-Dwyer</last_name>
      <phone>720-848-5146</phone>
      <email>emma.hulseberg-dwyer@ucdenver.edu</email>
    </contact>
    <investigator>
      <last_name>Michael McDermott, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hanson Clinical Research</name>
      <address>
        <city>Port Charlotte</city>
        <state>Florida</state>
        <zip>33952</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jay Cordona</last_name>
      <phone>941-764-9110</phone>
      <email>JAY@HANSONCRC.COM</email>
    </contact>
    <investigator>
      <last_name>Lenita Hanson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>East-West Medical Research Institute</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96814</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vutheary Hean</last_name>
      <phone>808-440-4466</phone>
      <email>VUTHEARY@EASTWESTRESEARCH.COM</email>
    </contact>
    <investigator>
      <last_name>David Fitz-Patrick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Suburban Endocrinology &amp; Diabetes</name>
      <address>
        <city>Arlington Heights</city>
        <state>Illinois</state>
        <zip>60005</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacqueline Bueno</last_name>
      <phone>847-981-0560</phone>
      <email>bueno.j@endocrinetrial.com</email>
    </contact>
    <investigator>
      <last_name>Mario Chan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Chicago Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luis Alcantar</last_name>
      <phone>773-702-1197</phone>
      <email>Lalcanta@bsd.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>Tamara Vokes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northshore University Health System</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sangeetha Rao</last_name>
      <phone>847-570-1761</phone>
      <email>srao@northshore.org</email>
    </contact>
    <investigator>
      <last_name>Stuart Sprague, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeanne Cercero</last_name>
      <phone>708-216-2058</phone>
      <email>jcerceo@luc.edu</email>
    </contact>
    <investigator>
      <last_name>Pauline Camacho</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Indiana University Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marian Hart</last_name>
      <phone>317-948-8346</phone>
      <email>Marihart@iu.edu</email>
    </contact>
    <investigator>
      <last_name>Munro Peacock, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tilak Mallik, MD F.A.C.E., LCC</name>
      <address>
        <city>Marrero</city>
        <state>Louisiana</state>
        <zip>70072</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tilak Mallik, MD</last_name>
      <phone>504-349-6520</phone>
      <email>TMALLIK@DOCTORMALLIK.COM</email>
    </contact>
    <contact_backup>
      <last_name>Baishali Mallik</last_name>
      <email>BMALLIK@DOCTORMALLIK.COM</email>
    </contact_backup>
    <investigator>
      <last_name>Tilak Mallik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Model Clinical Research</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Klein</last_name>
      <phone>443-524-1789</phone>
      <email>karenklein99@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Philip Levin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medstar Union Memorial Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ike Fleming</last_name>
      <phone>410-554-2486</phone>
      <email>Ike.c.fleming@medstar.net</email>
    </contact>
    <investigator>
      <last_name>Paul Sack, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Gentile</last_name>
      <phone>617-643-1694</phone>
      <email>egentile@mgh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Mannstadt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Conte</last_name>
      <phone>617-525-8003</phone>
      <email>sconte@partners.org</email>
    </contact>
    <investigator>
      <last_name>Anil Chandraker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catie Donlon</last_name>
      <phone>617-525-7009</phone>
      <email>cdonlon@partners.org</email>
    </contact>
    <investigator>
      <last_name>Sharon Chou, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tyler Kalajian</last_name>
      <phone>617-638-4546</phone>
      <email>Tylerk@bu.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Holick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shannon Smith</last_name>
      <email>srsmith@umn.edu</email>
    </contact>
    <investigator>
      <last_name>Tasma Harindhanavudhi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tamera Roberson</last_name>
      <phone>507-255-8621</phone>
      <email>Roberson.tamera@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Bart Clarke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Missouri</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Schneider</last_name>
      <phone>573-882-2549</phone>
      <email>schneiderri@health.missouri.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Zitsch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northern Nevada Endocrinology</name>
      <address>
        <city>Reno</city>
        <state>Nevada</state>
        <zip>89511</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shayla Vess</last_name>
      <phone>775-786-6770</phone>
      <email>VESSSHAYLA@GMAIL.COM</email>
    </contact>
    <investigator>
      <last_name>Lisa Abbott, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rutgers Robert Wood Johnson Medical School</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Varghese</last_name>
      <phone>732-235-7570</phone>
      <email>christinavarghese25@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ian Marshall, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rutgers Robert Wood Johnson Medical School</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juman Takeddin</last_name>
      <email>jt725@rwjms.rutgers.edu</email>
    </contact>
    <investigator>
      <last_name>Sara Lubitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brokhin Medical PC</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11223</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Sekansky</last_name>
      <phone>347-462-9292</phone>
      <email>csekansky@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Matvey Brokhin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy Fan</last_name>
      <phone>212-305-7364</phone>
      <email>wf2159@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>John Bilezikian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Endocrine Associates of Long Island, P.C.</name>
      <address>
        <city>Smithtown</city>
        <state>New York</state>
        <zip>11787</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Iannuzzi</last_name>
      <phone>631-265-5501</phone>
      <email>Islandendo@aol.com</email>
    </contact>
    <investigator>
      <last_name>Michael Shanik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Physicians Group Research Division</name>
      <address>
        <city>Staten Island</city>
        <state>New York</state>
        <zip>10301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bridget Recker</last_name>
      <phone>718-442-0300</phone>
      <email>research@upg.com</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Rothman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Joslin Diabetes Center at SUNY Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Bulger</last_name>
      <phone>315-464-9008</phone>
      <email>BulgerJ@upstate.edu</email>
    </contact>
    <investigator>
      <last_name>Ruban Dhaliwal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mecklenburg Medical Group</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dorothy Owens</last_name>
      <phone>704-302-8218</phone>
      <email>Dorothy.Owens@Carolinashealthcare.org</email>
    </contact>
    <investigator>
      <last_name>Gary Rolband, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Physicians East, PA</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristie Daly-Barnes</last_name>
      <phone>252-413-6232</phone>
      <email>kbarnes@physicianseast.com</email>
    </contact>
    <investigator>
      <last_name>Mark Warren, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debbie Latham</last_name>
      <phone>216-445-4944</phone>
      <email>LATHAMD2@CCF.ORG</email>
    </contact>
    <investigator>
      <last_name>Roy Kim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amber Anaya</last_name>
      <phone>614-688-6257</phone>
      <email>amber.anaya@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Steven Ing, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio Health Research Institute</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katy Groezinger</last_name>
      <phone>614-566-1255</phone>
      <email>KATY.GROEZINGER@OHIOHEALTH.COM</email>
    </contact>
    <investigator>
      <last_name>Michelle Kovalaske, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Endocrinology Associates of Armstrong</name>
      <address>
        <city>Indiana</city>
        <state>Pennsylvania</state>
        <zip>15701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samina Habibi</last_name>
      <phone>928-550-3103</phone>
      <email>saminahabibi@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Mushtaq Syed, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Pizza</last_name>
      <phone>267-426-3906</phone>
      <email>HUFFORD@EMAIL.CHOP.EDU</email>
    </contact>
    <investigator>
      <last_name>Michael Levine, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne Alfred</last_name>
      <email>JOANNE.ALFRED@JEFFERSON.EDU</email>
    </contact>
    <investigator>
      <last_name>Intekhab Ahmed, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hallett Center for Diabetes and Endocrinology</name>
      <address>
        <city>East Providence</city>
        <state>Rhode Island</state>
        <zip>02914</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Conti-Dutko</last_name>
      <email>JCONTI@LIFESPAN.ORG</email>
    </contact>
    <investigator>
      <last_name>Geetha Gopalakrishnan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of South Carolina</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diamond Herbert</last_name>
      <phone>803-545-5430</phone>
      <email>diamondherbert@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ali Rizvi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Diabetes and Endocrinology, P.A.</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78731</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>LILY AHN</last_name>
      <phone>512-334-3505</phone>
      <email>LAHN@TEXASDIABETES.COM</email>
    </contact>
    <investigator>
      <last_name>Valerie Espinosa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Diabetes and Thyroid Center of Fort Worth, PLLC</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chelsea Padilla</last_name>
      <phone>817-644-3807</phone>
      <email>CPADILLA@DTC-FW.COM</email>
    </contact>
    <investigator>
      <last_name>Chris Bajaj, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Robins</last_name>
      <phone>608-262-9799</phone>
      <email>ROBBINS@SURGERY.WISC.EDU</email>
    </contact>
    <investigator>
      <last_name>Becky Sippel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nova Scotia Health Authority</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 2Y9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Glenda McCarthy</last_name>
      <email>glenda.mccarthy@nshealth.ca</email>
    </contact>
    <investigator>
      <last_name>Stephanie Kaiser</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McMaster University</name>
      <address>
        <city>Oakville</city>
        <state>Ontario</state>
        <zip>L6J IX8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Namrah Siraj</last_name>
      <email>NAMRAH@BONERESEARCH.CA</email>
    </contact>
    <investigator>
      <last_name>Aliya Khan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aalborg University Hospital</name>
      <address>
        <city>Aalborg</city>
        <zip>9100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Vestergaard</last_name>
      <phone>+45-99403791</phone>
      <email>p-vest@post4.tele.dk</email>
    </contact>
    <investigator>
      <last_name>Peter Vestergaard</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus-C</city>
        <zip>DK8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Rejnmark</last_name>
      <phone>45-78467178</phone>
      <email>larsnien@rm.dk</email>
    </contact>
    <investigator>
      <last_name>Lars Rejnmark</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Regions Hospitalet Viborg</name>
      <address>
        <city>Viborg</city>
        <zip>8800</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Torben Østergard</last_name>
      <phone>45-78447599</phone>
      <email>TORBEN.OESTERGAARD@MIDT.RM.DK</email>
    </contact>
    <investigator>
      <last_name>Torben Østergard</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Denmark</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2013</study_first_submitted>
  <study_first_submitted_qc>August 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 14, 2013</study_first_posted>
  <last_update_submitted>May 17, 2018</last_update_submitted>
  <last_update_submitted_qc>May 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chronic Hypoparathyroidism</keyword>
  <keyword>rhPTH(1-84)</keyword>
  <keyword>Observational study</keyword>
  <keyword>parathyroid hormone (PTH)</keyword>
  <keyword>Drug registry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoparathyroidism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

